Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05720949 · ClinicalTrials.gov registry record · Phase 4
Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery
A Phase 4 study of Anterior Cruciate Ligament Injuries and ACL, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 192
- Enrollment target
- 1
- Study location
NCT05720949: Completed Phase 4 study of Anterior Cruciate Ligament Injuries and ACL, sponsored by Hospital for Special Surgery, New York.
NCT05720949 is a Phase 4 study of Anterior Cruciate Ligament Injuries and ACL that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 192 participants, below the 315-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05720949, a Phase 4 study of Anterior Cruciate Ligament Injuries and ACL, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized controlled trial is to assess a new analgesia regimen that includes the addition of genicular never blocks to our current standard regimen of peripheral nerve blocks, which includes an adductor canal block (ACB) and interspace between the popliteal artery and capsule of the posterior knee block (IPACK). The main questions it aims to answer are: 1. Does addition of genicular nerve blocks to standard peripheral block regimen significantly reduce the mean opioid consumption by 33% in the first 24 hours? 2. Does genicular nerve blocks reduce NRS pain scores? 3. Does genicular nerve blocks facilitate earlier discharge? 4. Does genicular nerve blocks last longer than 24 hours? 5. Does genicular nerve blocks improve pain management? Eligible patients are those undergoing an anterior cruciate ligament repair at the Hospital for Special Surgery and participants will be randomized to receive the intervention (genicular nerve block) or the standard of care.
Primary Outcome
Intravenous and Oral opioid consumption at 24 hours after recovery room entry will be recorded. The average consumption will be reported in morphine milligram equivalents.
Conditions Studied
Interventions
- DRUG Genicular Nerve Block with bupivacaine and preservative free dexamethasone
Study Locations (1)
New York
- HSS Sports Medicine Institute West Side - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2023-01-12 |
| Est. Completion | 2024-12-02 |
| Phase | Phase 4 |
What the finished NCT05720949 record still lists
NCT05720949 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 315-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 1 intervention - of which Genicular Nerve Block with bupivacaine and preservative free dexamethasone is the first listed.
NCT05720949 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05720949 about?
NCT05720949 is a clinical study titled "Genicular Nerve Blocks for Anterior Cruciate Ligament Knee Surgery". The purpose of this randomized controlled trial is to assess a new analgesia regimen that includes the addition of genicular never blocks to our current standard regimen of peripheral nerve blocks, which includes an adductor canal block (ACB) and interspace between the popliteal artery and capsule o...
What is the current status of trial NCT05720949?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 192 participants. The study started on 2023-01-12. Estimated completion is 2024-12-02.
What conditions does trial NCT05720949 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries, ACL.
What interventions are being tested in trial NCT05720949?
The interventions under investigation include: Genicular Nerve Block with bupivacaine and preservative free dexamethasone (DRUG).
Who is sponsoring clinical trial NCT05720949?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05720949 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05720949's enrollment target sits among peer trials
192 4th of 24 higher than 21 of 24 other Anterior Cruciate Ligament Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Concentrated Bone Marrow Aspirate in Revision ACL Reconstruction
RECRUITING · Phase 4
-
Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction
RECRUITING · Phase 4
-
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
RECRUITING · NA
-
Steps Towards Osteoarthritis Prevention
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI